• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Blocking myostatin: muscle mass equals muscle strength?

作者信息

Anker Markus S, von Haehling Stephan, Springer Jochen

机构信息

Berlin Institute of Health Center for Regenerative Therapies (BCRT), Charité Universitätsmedizin Berlin, Berlin, Germany.

German Centre for Cardiovascular Research (DZHK) partner site Berlin, Charité Universitätsmedizin Berlin, Berlin, Germany.

出版信息

J Cachexia Sarcopenia Muscle. 2020 Dec;11(6):1396-1398. doi: 10.1002/jcsm.12647.

DOI:10.1002/jcsm.12647
PMID:33340286
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7749583/
Abstract
摘要

相似文献

1
Blocking myostatin: muscle mass equals muscle strength?阻断肌肉生长抑制素：肌肉量等同于肌肉力量吗？
J Cachexia Sarcopenia Muscle. 2020 Dec;11(6):1396-1398. doi: 10.1002/jcsm.12647.
2
A mouse anti-myostatin antibody increases muscle mass and improves muscle strength and contractility in the mdx mouse model of Duchenne muscular dystrophy and its humanized equivalent, domagrozumab (PF-06252616), increases muscle volume in cynomolgus monkeys.一种抗肌生成抑制素的鼠单克隆抗体增加了 Duchenne 肌营养不良症的 mdx 小鼠模型和其人源化等效物 domagrozumab（PF-06252616）的肌肉质量，并改善了肌肉力量和收缩性，而在食蟹猴中，肌生成抑制素单克隆抗体增加了肌肉体积。
Skelet Muscle. 2017 Nov 9;7(1):25. doi: 10.1186/s13395-017-0141-y.
3
Effect of constitutive inactivation of the myostatin gene on the gain in muscle strength during postnatal growth in two murine models.在两种小鼠模型中，肌肉生长抑制素基因的组成性失活对出生后生长期间肌肉力量增加的影响。
Muscle Nerve. 2017 Feb;55(2):254-261. doi: 10.1002/mus.25220. Epub 2016 Nov 12.
4
A GDF11/myostatin inhibitor, GDF11 propeptide-Fc, increases skeletal muscle mass and improves muscle strength in dystrophic mdx mice.一种 GDF11/肌抑素抑制剂，GDF11 前肽-Fc，可增加肌营养不良症 mdx 小鼠的骨骼肌质量并改善肌肉力量。
Skelet Muscle. 2019 May 27;9(1):16. doi: 10.1186/s13395-019-0197-y.
5
The role of myostatin and bone morphogenetic proteins in muscular disorders.肌肉生长抑制素和骨形态发生蛋白在肌肉疾病中的作用。
Expert Opin Biol Ther. 2006 Feb;6(2):147-54. doi: 10.1517/14712598.6.2.147.
6
Myostatin and Insulin-Like Growth Factor 1 Are Biomarkers of Muscle Strength, Muscle Mass, and Mortality in Patients on Hemodialysis.肌肉生长抑制素和胰岛素样生长因子 1 是血液透析患者肌肉力量、肌肉质量和死亡率的生物标志物。
J Ren Nutr. 2019 Nov;29(6):511-520. doi: 10.1053/j.jrn.2018.11.010. Epub 2019 Jan 25.
7
Inhibition of myostatin prevents microgravity-induced loss of skeletal muscle mass and strength.抑制肌肉生长抑制素可防止微重力引起的骨骼肌质量和力量丧失。
PLoS One. 2020 Apr 21;15(4):e0230818. doi: 10.1371/journal.pone.0230818. eCollection 2020.
8
Regulation of muscle mass by myostatin.肌肉生长抑制素对肌肉量的调节
Annu Rev Cell Dev Biol. 2004;20:61-86. doi: 10.1146/annurev.cellbio.20.012103.135836.
9
Serum myostatin levels are independently associated with skeletal muscle wasting in patients with heart failure.血清肌抑素水平与心力衰竭患者的骨骼肌萎缩独立相关。
Int J Cardiol. 2016 Oct 1;220:483-7. doi: 10.1016/j.ijcard.2016.06.231. Epub 2016 Jun 27.
10
Myostatin Neutralization Results in Preservation of Muscle Mass and Strength in Preclinical Models of Tumor-Induced Muscle Wasting.肌生成抑制素中和可防止肿瘤诱导的肌肉消耗的临床前模型中的肌肉质量和力量损失。
Mol Cancer Ther. 2015 Jul;14(7):1661-70. doi: 10.1158/1535-7163.MCT-14-0681. Epub 2015 Apr 23.

引用本文的文献

1
Exploring in vivo and in vitro models for heart failure with biomarker insights: a review.基于生物标志物洞察探索心力衰竭的体内和体外模型：综述
Egypt Heart J. 2024 Oct 21;76(1):141. doi: 10.1186/s43044-024-00568-1.
2
Skeletal Muscle Injury in Chronic Kidney Disease-From Histologic Changes to Molecular Mechanisms and to Novel Therapies.慢性肾脏病中的骨骼肌损伤——从组织学变化到分子机制再到新疗法。
Int J Mol Sci. 2024 May 8;25(10):5117. doi: 10.3390/ijms25105117.
3
Biomarkers of Myocardial Injury and Remodeling in Heart Failure.心力衰竭中心肌损伤与重塑的生物标志物
J Pers Med. 2022 May 16;12(5):799. doi: 10.3390/jpm12050799.
4
Molecular Mechanisms and Current Treatment Options for Cancer Cachexia.癌症恶病质的分子机制与当前治疗选择
Cancers (Basel). 2022 Apr 23;14(9):2107. doi: 10.3390/cancers14092107.
5
Determining the contributions of protein synthesis and breakdown to muscle atrophy requires non-steady-state equations.确定蛋白质合成和分解对肌肉萎缩的贡献需要非稳态方程。
J Cachexia Sarcopenia Muscle. 2021 Dec;12(6):1764-1775. doi: 10.1002/jcsm.12772. Epub 2021 Aug 21.
6
Targeting the Activin Receptor Signaling to Counteract the Multi-Systemic Complications of Cancer and Its Treatments.靶向激活素受体信号通路以对抗癌症及其治疗的多系统并发症。
Cells. 2021 Feb 28;10(3):516. doi: 10.3390/cells10030516.

本文引用的文献

1
Characterization of cachexia in the human fibrosarcoma HT-1080 mouse tumour model.人成纤维肉瘤 HT-1080 小鼠肿瘤模型中恶病质的特征。
J Cachexia Sarcopenia Muscle. 2020 Dec;11(6):1813-1829. doi: 10.1002/jcsm.12618. Epub 2020 Sep 13.
2
Muscle NAD depletion and Serpina3n as molecular determinants of murine cancer cachexia-the effects of blocking myostatin and activins.肌肉 NAD 耗竭和 Serpina3n 作为小鼠癌性恶病质的分子决定因素-抑制肌肉生长抑制素和激活素的作用。
Mol Metab. 2020 Nov;41:101046. doi: 10.1016/j.molmet.2020.101046. Epub 2020 Jun 26.
3
Myostatin inhibition in combination with antisense oligonucleotide therapy improves outcomes in spinal muscular atrophy.肌抑素抑制联合反义寡核苷酸疗法改善脊髓性肌萎缩症的预后。
J Cachexia Sarcopenia Muscle. 2020 Jun;11(3):768-782. doi: 10.1002/jcsm.12542. Epub 2020 Feb 7.
4
Vitamin D repletion ameliorates adipose tissue browning and muscle wasting in infantile nephropathic cystinosis-associated cachexia.维生素 D 补充可改善婴儿遗传性胱氨酸病相关恶病质的脂肪组织褐变和肌肉减少。
J Cachexia Sarcopenia Muscle. 2020 Feb;11(1):120-134. doi: 10.1002/jcsm.12497. Epub 2019 Nov 13.
5
Ethical guidelines for publishing in the Journal of Cachexia, Sarcopenia and Muscle: update 2019.《恶病质、肌少症与肌肉杂志》发表伦理准则：2019 年更新版。
J Cachexia Sarcopenia Muscle. 2019 Oct;10(5):1143-1145. doi: 10.1002/jcsm.12501.
6
Autocrine activin A signalling in ovarian cancer cells regulates secretion of interleukin 6, autophagy, and cachexia.自分泌激活素 A 信号在卵巢癌细胞中调节白细胞介素 6 的分泌、自噬和恶病质。
J Cachexia Sarcopenia Muscle. 2020 Feb;11(1):195-207. doi: 10.1002/jcsm.12489. Epub 2019 Aug 21.
7
Inhibition of myostatin improves muscle atrophy in oculopharyngeal muscular dystrophy (OPMD).肌肉生长抑制素抑制可改善眼咽型肌营养不良症（OPMD）的肌肉萎缩。
J Cachexia Sarcopenia Muscle. 2019 Oct;10(5):1016-1026. doi: 10.1002/jcsm.12438. Epub 2019 May 7.
8
Amelioration of muscle wasting by glucagon-like peptide-1 receptor agonist in muscle atrophy.胰高血糖素样肽-1 受体激动剂改善肌肉萎缩引起的肌肉减少症。
J Cachexia Sarcopenia Muscle. 2019 Aug;10(4):903-918. doi: 10.1002/jcsm.12434. Epub 2019 Apr 24.
9
Compression of morbidity in a progeroid mouse model through the attenuation of myostatin/activin signalling.通过抑制肌肉生长抑制素/激活素信号通路来压缩早衰模型鼠的发病过程。
J Cachexia Sarcopenia Muscle. 2019 Jun;10(3):662-686. doi: 10.1002/jcsm.12404. Epub 2019 Mar 27.
10
Is muscle growth a mechanism for increasing strength?肌肉增长是否是增强力量的机制？
Med Hypotheses. 2019 Apr;125:51-56. doi: 10.1016/j.mehy.2019.02.030. Epub 2019 Feb 13.